Two Companies Restart Virus Trials in U.S. After Safety Pauses by BY KATHERINE J. WU AND CARL ZIMMER


AstraZeneca and Johnson & Johnson have restarted their late-stage trials after finding that serious illnesses in a few volunteers appeared not to be related to the vaccines.

Published: October 24, 2020 at 12:36AM

from NYT Health https://ift.tt/2FVcRmf